ARTICLE | Company News
Algene deal
December 7, 1998 8:00 AM UTC
AGN.B signed a letter of intent with an undisclosed biotechnology company for research into Alzheimer's disease. Under the terms of proposed agreement, AGN.B would obtain an initial one year research ...